Torrent Pharmaceuticals (TORNTPHARM) — Buyback / Redemption

Torrent Pharmaceuticals redeemed all ₹200 crores of commercial paper (CP) issued under ISIN INE685A14112 on March 26, 2025, fulfilling the maturity obligation without any remaining liability. The redemption reflects the company's disciplined debt management and commitment to timely repayment of short-term borrowings, reinforcing investor confidence in its financial governance.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

💡 Ask AI about this filing

"How does this buyback / redemption affect Torrent Pharmaceuticals Limited's outlook?" "What did Torrent Pharmaceuticals Limited announce on 26 March 2025?" "Is this positive or negative for TORNTPHARM?"

Ask AI Free →

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

🔥 Also filed on 26 March 2025

VEDL Vedanta Limited Financial Results BAJAJFINSV Bajaj Finserv Limited Announcement SBICARD SBI Cards and Payment Services Limited Financial Results UNIONBANK Union Bank of India Financial Results SBILIFE SBI Life Insurance Company Limited Financial Results BAJFINANCE Bajaj Finance Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.